Imatinib-Associated Pneumocystis jirovecii Pneumonia in a Patient With Chronic Myeloid Leukemia

Am J Ther. 2020 Jul/Aug;27(4):e406-e409. doi: 10.1097/MJT.0000000000000963.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Imatinib Mesylate / adverse effects*
  • Imatinib Mesylate / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Pneumocystis carinii
  • Pneumonia, Pneumocystis / etiology*

Substances

  • Antineoplastic Agents
  • Imatinib Mesylate